Answers are grounded in this paper and cite their sources.
Surface defects have been a key constraint for perovskite photovoltaics. Herein, 1,3-dimethyl-3-imidazolium hexafluorophosphate (DMIMPF₆ ) ionic liquid (IL) is adopted to passivate the surface of a formamidinium-cesium lead iodide perovskite (Cs0.08 FA0.92 PbI₃ ) and also reduce the energy barrier between the perovskite and hole transport layer. Theoretical simulations and experimental results demonstrate that Pb-cluster and Pb-I antisite defects can be effectively passivated by [DMIM]⁺ bonding with the Pb²⁺ ion on the perovskite surface, leading to significantly suppressed non-radiative recombination. As a result, the solar cell efficiency was increased to 23.25 % from 21.09 %. Meanwhile, the DMIMPF₆ -treated perovskite device demonstrated long-term stability because the hydrophobic DMIMPF₆ layer blocked moisture permeation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: